Information  X 
Enter a valid email address
  Print          More announcements

Friday 18 September, 2020

Financial Conduct

Listings of cannabis-related businesses

RNS Number : 4126Z
Financial Conduct Authority
18 September 2020
 

Listings of cannabis-related businesses

In response to queries from cannabis-related companies interested in listing in the UK, the FCA is today setting out its approach to assessing these applications. This is pending a guidance consultation which will follow in due course.  

While medicinal cannabis was legalised in the UK in 2018, investment in overseas-licensed medicinal cannabis businesses remains a legally complex area.  We consider that there remains a risk that the proceeds from overseas medicinal cannabis business may constitute 'criminal property' for the purpose of the Proceeds of Crime Act 2002 (PoCA).  This includes where the company possesses a licence issued by an overseas medicines or pharmaceuticals licensing authority. 

This is because PoCA defines ' criminal conduct', the key definition under the Act, deliberately broadly. It captures not only an offence in any part of the UK but also any conduct outside of the UK which would be criminal in the UK if carried out here.  Possessing and supplying cannabis for recreational use remains a criminal offence in the UK. If a pharmaceutical company supplied cannabis in the UK without appropriate Home Office licences, they would be committing a criminal offence.  We can't assume a person who has been licensed in an overseas country would receive a licence here in the UK as licensing regimes differ globally.

Recreational cannabis companies

The proceeds from recreational cannabis companies, even when they are located in those jurisdictions that have legalised it, are proceeds of crime under PoCA.  We would therefore not admit the securities of such a company to the Official List.

UK-based companies

The legal position of purely UK-based medicinal cannabis companies and cannabis oil companies is clear.  UK-based medicinal cannabis companies can be admitted to the Official List, if the company has the appropriate Home Office licences for their activities where they are required.

Overseas companies

Overseas-licensed medicinal cannabis companies and cannabis oil companies are in a different position.  These companies may be admitted to the Official List, provided we are satisfied PoCA does not apply and they otherwise satisfy the criteria for listing.  Before they are admitted, we will carry out a review of their case where they will need to satisfy us as to the PoCA risk.

For medicinal cannabis and cannabis oil companies with overseas activities, the company will need to satisfy us that their activities would be legal if carried out in the UK. We will also need to understand the legal basis of the company's overseas activities, for example the nature of the local licensing and the licences the company holds.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IRSGZGMLVRRGGZG

a d v e r t i s e m e n t